Abstract
Somatoform disorders as a group cause significant physical and emotional distress. They impair occupational and social function. They are associated with increased work absences, more time spent in bed, a lower quality of life, an increased risk for iatrogenic injury, and increased health-care utilization and costs. The accompanying impairment is comparable to that seen with mood and anxiety disorders [1]. Fortunately, effective treatment strategies exist that can improve somatoform conditions, reinforcing the importance of identifying and engaging affected patients. This remains true despite the challenges inherent in the nature of managing symptoms with no identifiable tissue pathology.
Similar content being viewed by others
References
Kroenke K, Spitzer R, DeGruy F, Swindle R. A symptom checklist to screen for somatoform disorders in primary care. Psychosomatics. 1998;39:263–72.
Perley MJ, Guze SB. Hysteria-the stability and usefulness of clinical criteria. N Engl J Med. 1962;266:241–6.
Dimsdale J, Xin Y, Kleinman A, et al. Somatic presentations of mental disorders. Refining the research agenda for DSM-V. Arlington: American Psychiatric Association; 2009.
Nutt DJ, Stein DJ. Understanding the neurobiology of comorbidity in anxiety disorders. CNS Spectr. 2006;11:13–20.
Stuart S, Noyes R. Attachment and interpersonal communication in somatization. Psychosomatics. 1999;40:34–43.
Simon GE, VonKorff M. Somatization and psychiatric disorder in the NIMH epidemiologic catchment area study. Am J Psychiatry. 1991;148:1494–500.
Reiger DA, Myers JK, Kramer M, et al. The NIMH epidemiologic catchment area program. Arch Gen Psychiatry. 1984;41:934–41.
Lipowski ZJ. Somatization and depression. Psychosomatics. 1999;31:13–21.
Katon W, Lin E, Korff V, et al. Somatization: a spectrum of severity. Am J Psychiatry. 1990;148:34–40.
Regier DA, Darmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264:2511–8.
Katon W, Sullivan M, Walker E. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med. 2001;134:917–25.
Bass C, Murphy M. Somatoform and personality disorders: syndromal comorbidity and overlapping developmental pathways. J Psychosom Res. 1995;39:403–27.
Bass C, Murphy MR. The chronic somatizer and the government white paper. J R Soc Med. 1990;83:203–5.
Sharpe M, Bass C. Pathophysiologic mechanisms in somatization. Int Rev Psychiatry. 1992;4:81–97.
Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Trends Neurosci. 2002;25:154–9.
Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2000;27:24–31.
Strickiland PL, Deakin JF, Percival C, Dixon J, Gater A, Goldberg D. Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br J Psychiatry. 2002;180:168–73.
Capuron L, Ravaud A, Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol. 2000;18:2143–51.
Capuron L, Raison CL, Musselman DL, Lawson DH, Nemeroff CB, Miller AH. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during therapy. Am J Psychiatry. 2003;160:1342–5.
Watkins LR, Hutchinson MR, Ledeboer A, Wiesler-Frank J, Milligan ED, Maier SF. Glia as the “bad guys”: implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun. 2007;21:131–46.
Kellner R. Somatization: theories and research. J Nerv Ment Dis. 1990;178:150–60.
Kleinman A. Social origins of distress and disease: depression, neuroasthenia, and pain in Modern China. New Haven: Yale University Press; 1986.
House JS, Landis KR, Umberson D. Social relationships and health. Science. 1988;241:540–5.
Katon W, Ries RK, Kleinman A. The prevalence of somatisation in primary care. Compr Psychiatry. 1984;25:208–15.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
Eastwood S, Bisson J. Management of factitious disorders: a systematic review. Psychother Psychosom. 2008;77:209–18.
Nussbaum A. The pocket guide to the DSM-5 diagnostic exam. Arlington: American Psychiatric Association; 2013.
Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom. 2000;69:205–15.
O’Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract. 1999;48:980–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this entry
Cite this entry
Pentin, P., Sperry, L.D. (2015). Somatoform Disorders and Related Syndromes. In: Paulman, P., Taylor, R. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0779-3_35-1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0779-3_35-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4939-0779-3
eBook Packages: Springer Reference MedicineReference Module Medicine